Back to All NewsFDA Approves New Breast Implant
Posted By American Med Spa Association, Wednesday, January 25, 2017
Share
Earlier this month, the U.S. Food and Drug Administration (FDA) approved Allergan’s Natrelle Inspira SoftTouch breast implants, which provide a medium-firm gel option for women undergoing breast reconstruction, augmentation, or revision surgery.
With this addition, the Natrelle line of breast implants is the only implant line with three levels of cohesive gel. "Adding Natrelle Inspira SoftTouch breast implants to our already robust line of offerings gives Allergan the most extensive variety of implants in the industry and provides doctors with a wide range of options," says David Nicholson, chief research and development officer of Allergan.
"Now, the Inspira line of breast implants helps physicians to better meet diverse, patient-specific needs based on available breast tissue and desired outcomes. We're delighted to have this offering available in the U.S. since they are so popular with doctors and patients internationally."
Read more at American Spa Magazine >>
With this addition, the Natrelle line of breast implants is the only implant line with three levels of cohesive gel. "Adding Natrelle Inspira SoftTouch breast implants to our already robust line of offerings gives Allergan the most extensive variety of implants in the industry and provides doctors with a wide range of options," says David Nicholson, chief research and development officer of Allergan.
"Now, the Inspira line of breast implants helps physicians to better meet diverse, patient-specific needs based on available breast tissue and desired outcomes. We're delighted to have this offering available in the U.S. since they are so popular with doctors and patients internationally."
Read more at American Spa Magazine >>
